Conférences - Biotechnologie - États-Unis

Sélecionner un pays
1
POC — CHI's Enabling Point-of-Care Diagnostics
24 aou 2021 - 25 aou 2021 • Washington, DC, États-Unis
Organisateur:
Cambridge Healthtech Institute (CHI)
Résumé:
Point-of-care testing stands to revolutionize all aspects of medicine by providing rapid test results, patient access to data and a broad range of tests available. The need for self-testing and rapid turnaround was brought to light during the COVID-19 pandemic and the field is expanding to enable and ensure a steady supply chain, reliable results, interconnectivity of platforms and management of health data by consumers. The goal of the POCT community is to meet the current demands in the market. Join us at this conference at the Next Generation Dx Summit.
Contact:
Tél.: [781-972-5400];     Email.: reg@healthtech.com
Sujets:
point-of care, POCT, diagnostics, point-of-care diagnostics, diagnostic test, diagnostic testing, pathology, infectious disease, infectious diseases, test for disease, SARS-COV2, microfluidics, COVID-19, biotechnology
Identifiant de l'évènement:
1411654
Sujets apparentés:
2
CDD — CHI's Drug-Diagnostics Co-Development
24 aou 2021 - 25 aou 2021 • Washington, DC, États-Unis
Organisateur:
Cambridge Healthtech Institute (CHI)
Résumé:
This conference is designed to facilitate knowledge and opinion exchange between pharmaceutical and diagnostics executives, translational scientists, clinicians, business experts, regulators, international companion diagnostics leaders, and other parties involved in drug-diagnostics co-development and precision medicine. Case studies of successful collaboration between pharmaceutical and diagnostics companies will be presented. This conference is part of the Next Generation Dx Summit.
Contact:
Tél.: [781-972-5400];     Email.: reg@healthtech.com
Sujets:
drug, diagnostics, drug-diagnostics, medicare, drug reimbursement, diagnostic reimbursement, technology, technologies, lab tests, pharmaceuticals, biomarkers, immuno-oncology, precision medicine
Identifiant de l'évènement:
1411642
3
ADX — CHI's 13th Annual Next Generation Dx Summit
24 aou 2021 - 26 aou 2021 • Washington, DC, États-Unis
Organisateur:
Cambridge Healthtech Institute (CHI)
Résumé:
Advancing Diagnostics Together: In-Person & Virtual offerings with complete coverage of the most timely and important issues for the diagnostics industry. Register with Confidence: Select an In-person or virtual option, and you have the flexibility to switch your preferred event experience at any time leading up to the conference. Our flexible registration is designed to take the uncertainties out of these uncertain times.
Contact:
Tél.: [781-972-5400];     Email.: reg@healthtech.com
Sujets:
POCT, diagnostics, drug-diagnostic, liquid biopsy, liquid biopsies, regulation, FDA, infectious diseases, CRISPR, microbiology, diagnostic testing, diagnostic test, COVID-19, NGS, molecular testing
Identifiant de l'évènement:
1411600
Sujets apparentés:
4
IDX — CHI's Advanced Diagnostics for Infectious Disease
25 aou 2021 - 26 aou 2021 • Washington, DC, États-Unis
Organisateur:
Cambridge Healthtech Institute (CHI)
Résumé:
At this conference, leaders working in the clinical lab, research, biotech, and pharma will come together to showcase the latest in diagnostic technology and find solutions for the biggest challenges facing the clinical lab, including managing workflow, incorporating NGS and molecular testing, gaining reimbursement and regulatory approval, and more. This conference is part of the Next Generation Dx Summit.
Contact:
Tél.: [781-972-500];     Email.: reg@healthtech.com
Sujets:
diagnostics, advanced diagnostics, infectious diseases, infectious disease testing, molecular diagnostic test, MDx test, COVID-19, CRISPR, pandemics, POCT
Identifiant de l'évènement:
1411717
5
LBY — CHI's Technologies for Liquid Biopsy
25 aou 2021 - 26 aou 2021 • Washington, DC, États-Unis
Organisateur:
Cambridge Healthtech Institute (CHI)
Résumé:
Liquid biopsies, including CTCs, cfDNA, mRNA, exosomes and EVs, have dominated the headlines for the past decade and presently new liquid biopsy tests are gaining regulatory approval and entering the clinic. These will enable improved diagnosis of cancer, minimal residual disease, early detection, and a new era of companion diagnostics for therapy selection, monitoring, outcome prediction, and risk of recurrence. New devices are being engineered to both isolate CTCs and destroy them with lasers, and microfluidic technologies are enabling advanced platforms to better diagnose, prognose, and treat disease. This conference is a part of the Next Generation Dx Summit.
Contact:
Tél.: [781-972-5400];     Email.: reg@healthtech.com
Sujets:
liquid biopsy, liquid biopsies, CTCs, cfDNA, mRNA, exosomes, EVs, cancer, cancer tumor cells, cell, tumor, diagnostics, diagnose, metastatics, cancer surgery, surgery, surgical, companion diagnostics
Identifiant de l'évènement:
1411694
Sujets apparentés:
6
Gordon Research Seminar — Antibody Biology and Engineering
12 mar 2022 - 13 mar 2022 • Ventura, États-Unis
Identifiant de l'évènement:
1377672
7
Gordon Research Conference — Antibody Biology and Engineering
13 mar 2022 - 18 mar 2022 • Ventura, États-Unis
Identifiant de l'évènement:
1377640


Conference-Service.com met à la disposition de ses visiteurs des listes de conférences et réunions dans le domaine scientifique. Ces listes sont publiées pour le bénéfice des personnes qui cherchent une conférence, mais aussi, bien sûr, pour celui des organisateurs. Noter que, malgré tout le soin que nous apportons à la vérification des données entrées dans nos listes, nous ne pouvons accepter de responsabilité en ce qui concerne leur exactitude ou étendue. Pensez donc à vérifier les informations présentées avec les organisateurs de la conférence ou de la réunion avant de vous engager à y participer!

Dernière mise à jour: 03 Mars 2021